Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants
Clinical trial NCT03226275 · COMPLETED
Trial details
- NCT number
- NCT03226275
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-09
- Primary completion
- 2017-09-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.